| dc.contributor.author | Callejas Rubio, José Luis | |
| dc.contributor.author | Aomar Millán, I. | |
| dc.contributor.author | Moreno Higueras, M. | |
| dc.contributor.author | Martín Ripoll, L. | |
| dc.contributor.author | Yuste Osorio, E. | |
| dc.contributor.author | Rios Fernández, Raquel | |
| dc.date.accessioned | 2025-01-28T11:21:59Z | |
| dc.date.available | 2025-01-28T11:21:59Z | |
| dc.date.issued | 2021-12 | |
| dc.identifier.citation | Callejas Rubio JL, Aomar Millan I, Moreno-Higueras M, Martín Ripoll L, Yuste Osorio E, Ríos-Fernández R. Caution with the use of dexamethasone in patients with COVID-19 in its initial phases. Rev Clin Esp (Barc). 2021 Dec;221(10):592-595. doi: 10.1016/j.rceng.2021.02.005. Epub 2021 Sep 17. (IF: 1.3; Q3) | es_ES |
| dc.identifier.uri | https://hdl.handle.net/10481/100736 | |
| dc.language | eng | |
| dc.publisher | Rev Clin Esp | es_ES |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
| dc.title | Caution with the use of dexamethasone in patients with COVID-19 in its initial phases | es_ES |
| dc.type | journal article | es_ES |
| dc.rights.accessRights | open access | es_ES |
| dc.identifier.doi | 10.1016/j.rceng.2021.02.005 | |